[1]
|
Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R.L., Bardelli, A. and Bernards, R. (2012) Unresponsiveness of Colon Cancer to BRAF (V600E) Inhibition through Feedback Activation of EGFR. Nature, 483, 100-103. https://doi.org/10.1038/nature10868
|
[2]
|
Ribas, A. and Flaherty, K.T. (2011) BRAF Targeted Therapy Changes the Treatment Paradigm in Melanoma. Nature Reviews Clinical Oncology, 8, 426-433. https://doi.org/10.1038/nrclinonc.2011.69
|
[3]
|
Sasaki, T., Rodig, S.J., Chirieac, L.R. and Janne, P.A. (2010) The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer. European Journal of Cancer, 46, 1773-1780. https://doi.org/10.1016/j.ejca.2010.04.002
|
[4]
|
Scagliotti, G., Stahel, R.A., Rosell, R., Thatcher, N. and Soria, J.C. (2012) ALK Translocation and Crizotinib in Non-Small Cell Lung Cancer: An Evolving Paradigm in Oncology Drug Development. European Journal of Cancer, 48, 961-973. https://doi.org/10.1016/j.ejca.2012.02.001
|
[5]
|
Sequist, L.V., Waltman, B.A., Dias-Santagata, D., Digumarthy, S., Turke, A.B., Fidias, P., Bergethon, K., Shaw, A.T., Gettinger, S., Cosper, A.K., Akhavanfard, S., Heist, R.S., Temel, J., Christensen, J.G., Wain, J.C., Lynch, T.J., Vernovsky, K., Mark, E.J., Lanuti, M., Iafrate, A.J., Mino-Kenudson, M. and Engelman, J.A. (2011) Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors. Science Translational Medicine, 3, 75ra26. https://doi.org/10.1126/scitranslmed.3002003
|
[6]
|
Shaw, A.T. and Solomon, B. (2011) Targeting Anaplastic Lymphoma Kinase in Lung Cancer. Clinical Cancer Research, 17, 2081-2086. https://doi.org/10.1158/1078-0432.CCR-10-1591
|
[7]
|
Smalley, K.S. and McArthur, G.A. (2012) The Current State of Targeted Therapy in Melanoma: This Time It’s Personal. Seminars in Oncology, 39, 204-214. https://doi.org/10.1053/j.seminoncol.2012.01.008
|
[8]
|
Sotiriou, C. and Pusztai, L. (2009) Gene-Expression Signatures in Breast Cancer. The New England Journal of Medicine, 360, 790-800. https://doi.org/10.1056/NEJMra0801289
|
[9]
|
Su, K.Y., Chen, H.Y., Li, K.C., Kuo, M.L., Yang, J.C., Chan, W.K., Ho, B.C., Chang, G.C., Shih, J.Y., Yu, S.L. and Yang, P.C. (2012) Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients with Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 30, 433-440. https://doi.org/10.1200/JCO.2011.38.3224
|
[10]
|
Subramanian, J. and Govindan, R. (2008) Molecular Genetics of Lung Cancer in People Who Have Never Smoked. The Lancet Oncology, 9, 676-682. https://doi.org/10.1016/S1470-2045(08)70174-8
|
[11]
|
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., Lim Choi, Y., Satoh, Y., Okumura, S., Nakagawa, K., Mano, H. and Ishikawa, Y. (2012) RET, ROS1 and ALK Fusions in Lung Cancer. Nature Medicine, 18, 378-381. https://doi.org/10.1038/nm.2658
|
[12]
|
Tran, B., Dancey, J.E., Kamel-Reid, S., McPherson, J.D., Bedard, P.L., Brown, A.M., Zhang, T., Shaw, P., Onetto, N., Stein, L., Hudson, T.J., Neel, B.G. and Siu, L.L. (2012) Cancer Genomics: Technology, Discovery, and Translation. Journal of Clinical Oncology, 30, 647-660. https://doi.org/10.1200/JCO.2011.39.2316
|
[13]
|
Van Cutsem, E., Kohne, C.H., Lang, I., Folprecht, G., Nowacki, M.P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., Schlichting, M., Zubel, A., Celik, I., Rougier, P. and Ciardiello, F. (2011) Cetuximab plus Irinotecan, Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. Journal of Clinical Oncology, 29, 2011-2019. https://doi.org/10.1200/JCO.2010.33.5091
|
[14]
|
van Krieken, J.H., Jung, A., Kirchner, T., Carneiro, F., Seruca, R., Bosman, F.T., Quirke, P., Flejou, J.F., Plato Hansen, T., de Hertogh, G., Jares, P., Langner, C., Hoefler, G., Ligtenberg, M., Tiniakos, D., Tejpar, S., Bevilacqua, G. and Ensari, A. (2008) KRAS Mutation Testing for Predicting Response to anti-EGFR Therapy for Colorectal Carcinoma: Proposal for an European Quality Assurance Program. Virchows Archiv, 453, 417-431. https://doi.org/10.1007/s00428-008-0665-y
|
[15]
|
Weinstein, I.B. (2002) Cancer. Addiction to Oncogenes—The Achilles Heal of Cancer. Science, 297, 63-64. https://doi.org/10.1126/science.1073096
|
[16]
|
Engel, N., Gossauer, A., Gruber, K. and Kratky, C. (1993) X-Ray Molecular Structure of a Red Bilin Derivative from Chlorella Protothecoides. 4th Communication on Chlorophyll Catabolism. Helvetica Chimica Acta, 76, 2236-2238. https://doi.org/10.1002/hlca.19930760607
|
[17]
|
Boiadjiev, S.E. and Lightner, D.A. (2000) Chirality Inversion in a Molecular Exciton. Journal of the American Chemical Society, 122, 378-383. https://doi.org/10.1021/ja993242b
|
[18]
|
Dan Pantos, G., Salome Rodriguez-Morgade, M., Torres, T., Lynch, V.M. and Sessler, J.L. (2006) 2-Amino-3, 4-Diethylpyrrole Derivatives: New Building Blocks for Coiled Structures. Chemical Communications, No. 20, 2132-2134. https://doi.org/10.1039/B602956F
|
[19]
|
Haketa, Y. and Maeda, H. (2011) From Helix to Macrocycle: Anion-Driven Conformation Control of π-Conjugated Acyclic Oligopyrroles. Chemistry: A European Journal, 17, 1485-1492. https://doi.org/10.1002/chem.201002748
|
[20]
|
Haketa, Y., Bando, Y., Takaishi, K., Uchiyama, M., Muranaka, A., Naito, M., Shibaguchi, H., Kawai, T. and Maeda, H. (2012) Asymmetric Induction in the Preparation of Helical Receptor-Anion Complexes: Ion-Pair Formation with Chiral Cations. Angewandte Chemie, 124, 8091-8095. https://doi.org/10.1002/ange.201202196
|
[21]
|
Juwarker, H. and Jeong, K.-S. (2010) Anion-Controlled Foldamers. Chemical Society Reviews, 39, 3664-3674. https://doi.org/10.1039/b926162c
|
[22]
|
Dolphin, D., Harris, R.L.N., Huppatz, J.L., Johnson, A.W., Kay, I.T. and Leng, J. (1966) The Synthesis of 5,5-Bi-(Dipyrromethenyls) and Related Compounds. Journal of the Chemical Society C, 98-106. https://doi.org/10.1039/j39660000098
|
[23]
|
Murakami, Y., Matsuda, H. and Kanaoka, Y. (1971) Transition-Metal Complexes of Pyrrole Pigments. III. Copper(II) and Zinc(II) Complexes of 1,19-Dideoxy-8,12-Dicarbethoxy-1,3,7,13,17,19-Hexamethylbiladiene-ac. Bulletin of the Chemical Society of Japan, 44, 409-415.
|
[24]
|
Struckmeier, G., Thewalt, U. and Fuhrhop, J.-H. (1976) Structures of Zinc Octaethyl Formylbiliverdinate Hydrate and Its Dehydrated Bis-Helical Dimer. Journal of the American Chemical Society, 98, 278-279. https://doi.org/10.1021/ja00417a067
|
[25]
|
Sheldrick, W.S. and Engel, J. (1980) X-Ray Crystal Structure of the Zinc Complex of 1,2,3,7,8,12,13,17,18,19-Decame- thylbiladiene-a,c. Journal of the Chemical Society, Chemical Communications, 23, 5-6.
|
[26]
|
Thompson, A. and Dolphin, D. (2000) Double-Helical Dinuclear Bis(dipyrromethene) Complexes Formed by Self-Assembly. The Journal of Organic Chemistry, 65, 7870-7877. https://doi.org/10.1021/jo000886p
|